Will I regain the weight if I stop using Foundayo 17.2MG PEPTIDE in San Jose California

Weight regain after stopping GLP-1 receptor agonists—including orforglipron (Foundayo)—is a well-documented phenomenon because obesity is generally considered a chronic, progressive condition. The Reality of Weight RegainWhen you stop taking What side effects are normal vs dangerous of Foundayo 17.2MG PEPTIDE in San Jose California these medications, you are essentially removing the physiological "brakes" on your appetite. Without the medication to regulate GLP-1 receptors, your body's natural hunger hormones often return to their previous levels, leading to an increase in appetite and the return of "food noise" (persistent thoughts about food). Clinical Observations: Studies across the GLP-1 class (including semaglutide and tirzepatide) show that many patients regain a significant portion of their lost weight within the first year of cessation. Research indicates that patients may regain, on average, two-thirds of their lost weight within 12 months of stopping.